Clinical Trials Browser

Uterine Cervical Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Advanced Lung Cancer

Meningeal Carcinomatosis

Pancreatic Cancer Metastatic

Uterine Cervical Neoplasms

Advanced Lung Cancer

Advanced Solid Tumor

Pancreatic Neoplasms

Carcinoma, Hepatocellular

Advanced Pancreatic Cancer

Locally Advanced or Metastatic Solid Tumors

Head and Neck Squamous Cell Cancer

Carcinoma, Hepatocellular

Nasopharyngeal Carcinoma

Lymphoma, Large B-Cell, Diffuse, Pyloric Stenosis, Hypertrophic

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Esophageal Squamous Cell Carcinoma

Carcinoma, Hepatocellular

Carcinoma, Non-Small-Cell Lung, Recurrence

Colonic Neoplasms

Uterine Cervical Neoplasms

Liver Neoplasms

Clinical Trials

Anti-PD-1 Antibody Combined With Histone Deacetylase Inhibitor in Patients With Advanced Cervical Cancer

Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver Metastases

Combination Immunotherapy for the Treatment of Chemotherapy-refractory Metastatic MSS CRC

JS004 Combined With Toripalimab and With Standard Chemotherapy Treat Patients With Advanced Lung Cancer

Safety and Tolerability of a mRNA Vaccine Encoding Tumor-Specific Circular RNA Antigens in Combination With Anti-PD-1 Monoclonal Antibody in Patients With Advanced Solid Tumors

Immune Checkpoint Inhibitor Combined With Pemetrexed Intrathecal Injection for Leptomeningeal Metastasis From Solid Tumors

A Phase Ib/II Clinical Study of Regorafenib Combined With Toripalimab and Albumin-bound Paclitaxel for the Third-line Treatment of Advanced Pancreatic Cancer

Induction Toripalimab and Chemotherapy in Locally Advanced Cervical Cancer

Study of JS004 Combined With Toripalimab for Advanced Lung Cancer

A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid Tumors

Immunotherapy Rechallenge in Patients with Solid Tumors in Clinical Trials

FD-IMPACT

Safety and Efficacy of RX-af01 Combined With PD-1 Antibody

Toripalimab in Combination With Lenvatinib as Neoadjuvant Therapy in Resectable Hepatocellular Carcinoma

Safety, Pharmacokinetics and Efficacy of CT-707, Toripalimab and Gemcitabine in Advanced Pancreatic Cancer

IFNα Expressing Mesenchymal Stromal Cells for Locally Advanced/Metastatic Solid Tumors

A Study of Toripalimab Injection (JS001) + Cetuximab in Treatment of Advanced Head and Neck Squamous Cell Cancer

Thermal Ablation Followed by Immunotherapy for HCC

Interferon-α1b Combined With Toripalimab and Anlotinib Hydrochloride in Advanced Unresectable Melanoma

PD-1 Blockade and Bevacizumab Replace Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma

Toripalimab Plus Rituximab Followed by R-CHOP for Elderly Patients With Untreated Diffused B Cell Lymphoma

The Study to Evaluate Toripalimab (JS001) in Patients With Advanced GC, ESCC, NPC, HNSCC

Toripalimab

CT32

JSFOL

CCRT+PD-1

STUHCCPVTT

Toripalimab With Preoperative Chemoradiotherapy for LA-EGJ